NOAH M SARR
Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Psychiatric/Mental Health FRESNO, CA NPI 1114377686
Browse related groups: Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner|Psychiatric/Mental Health CA Amgen Inc. All categories
General Payments — all program years on this page
$10,693.72
- Category: General Payments
- Program years: PY2021–2024
- Record count: 677
- As of (CMS publication): 2026-01-23
Latest program year (PY2024): $1,246.60 across 74 records · disputed records: 0
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How this figure is calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
Latest program year (PY2024) · sorted by reported total.
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $1,246.60 | 74 |
By paying entity
Latest program year (PY2024) · sorted by reported total.
| Paying entity | Amount | Records |
|---|---|---|
| Amgen Inc. | $173.64 | 10 |
| ABBVIE INC. | $151.35 | 9 |
| Novo Nordisk AS | $137.51 | 20 |
| E.R. Squibb & Sons, L.L.C. | $118.39 | 1 |
| Otsuka America Pharmaceutical, Inc. | $83.47 | 4 |
| Merck Sharp & Dohme Corporation | $61.49 | 3 |
| Lundbeck LLC | $50.80 | 2 |
| Bayer HealthCare Pharmaceuticals Inc. | $43.87 | 2 |
| PFIZER INC. | $43.25 | 2 |
| Antares Pharma, Inc. | $42.53 | 2 |
| ITI, Inc. | $39.00 | 2 |
| Astellas Pharma US Inc | $37.23 | 2 |
| Acerta Pharma LLC | $33.84 | 2 |
| Boehringer Ingelheim Pharmaceuticals, Inc. | $30.67 | 2 |
| IRONWOOD PHARMACEUTICALS, INC | $29.83 | 2 |
| NOVARTIS PHARMACEUTICALS CORPORATION | $27.33 | 2 |
| Axsome Therapeutics, Inc. | $25.22 | 1 |
| Hologic Sales and Service, LLC | $24.69 | 1 |
| Takeda Pharmaceuticals U.S.A., Inc. | $19.74 | 1 |
| OptiNose US, Inc. | $18.63 | 1 |
| GlaxoSmithKline, LLC. | $18.60 | 1 |
| Agile Therapeutics, Inc. | $18.52 | 1 |
| Neurocrine BioSciences, Inc. | $17.00 | 1 |
By program year
Records — PY2024 (74)
Provenance & corrections
- Dataset: CMS Open Payments — General Payments
- Source: CMS Open Payments dataset (bulk file)
- Publisher of source data: Centers for Medicare & Medicaid Services
- Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.